Is Pembrolizumab produced in China?

It is understood that Pembrolizumab has not yet been launched as a domestic drug produced by domestic pharmaceutical companies. Pembrolizumab sold in China is an imported drug. Pembrolizumab is an immune checkpoint inhibitor used to treat many types of cancer. It enhances the ability of immune cells to attack tumor cells by inhibiting the PD-1 receptor in the immune system. Studies have shown that pembrolizumab has shown good efficacy in the treatment of malignant melanoma, non-small cell lung cancer, renal cell carcinoma, Hodgkin lymphoma and head and neck squamous cell carcinoma. For patients with these cancers, pembrolizumab may provide an effective treatment option.